Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.
Dr. Rubin highlights a new subcutaneous induction for UC, stressing convenience, access, and sustained remission.
In this episode presented by PII, BioSpace’s head of insights discusses with guests Oliver Eden and Travis Webb how autoinjectors offer opportunities to improve delivery systems, patient compliance ...
Hosted on MSN
The Medicine Cabinet: Ask the Harvard Experts: When to consider injections for knee osteoarthritis
Q: I have osteoarthritis in both knees. The left knee is especially painful and stiff. When should a person consider getting knee injections? A: People can often manage the pain and improve mobility ...
After launching a multi-campus phased rollout of the predictive insulin dosing software, Philadelphia-based Temple Health’s University Hospital has reduced hypoglycemia rates two- to threefold. The ...
Subcutaneous daratumumab is well tolerated, but ongoing immune monitoring is key to managing infection risk in patients with multiple myeloma. While the use of subcutaneous daratumumab and ...
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Daily Sudoku Together ...
Averee Dovsek explains how to execute the dead-arm chip to reduce wrist breakdown and achieve more consistent results around the green.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback